Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05423730 · ClinicalTrials.gov registry record · NA
Alcohol and Breast Cancer (ABC) Trial
A NA study, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 23
- Enrollment target
NCT05423730 is a NA study that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 23 participants.
The verdict
NCT05423730, a NA study, has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 23 participants
- Enrollment target
Study Summary
This research study is a pilot study, which is the first time investigators are examining the effect of light alcohol consumption on sex hormones among postmenopausal women with estrogen receptor-positive (ER+) breast cancer taking an aromatase inhibitor The names of the study exposures involved in this study are: * White wine * White grape juice
Interventions
- OTHER White Wine
- OTHER Grape Juice
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2022-09-01 |
| Est. Completion | 2023-07-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05423730
The ClinicalTrials.gov registry entry for NCT05423730 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which White Wine is the first listed.
NCT05423730 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05423730 about?
NCT05423730 is a clinical study titled "Alcohol and Breast Cancer (ABC) Trial". This research study is a pilot study, which is the first time investigators are examining the effect of light alcohol consumption on sex hormones among postmenopausal women with estrogen receptor-positive (ER+) breast cancer taking an aromatase inhibitor The names of the study exposures involved in...
What is the current status of trial NCT05423730?
This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2022-09-01. Estimated completion is 2023-07-31.
What interventions are being tested in trial NCT05423730?
The interventions under investigation include: White Wine (OTHER), Grape Juice (OTHER).
Who is sponsoring clinical trial NCT05423730?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.